Nuwellis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nuwellis, Inc. (Nasdaq: NUWE) on January 21, 2026. The filing addresses significant changes to the composition of the Company's Board of Directors, including the resignation of three directors and the appointment of two new independent directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignations: Dave McDonald, Mike McCormick, and Dr. Maria Costanzo resigned from the Board and their respective committees effective January 21, 2026. The resignations were not due to any disagreement with the Company regarding operations, policies, or practices.
- Board Size Reduction: The Board size was reduced from six (6) to five (5) members.
- New Appointments: Katharyn Field and Mika Grasso were appointed as independent directors effective January 21, 2026. Both are designated as Class I directors with terms expiring at the 2026 annual meeting.
Outlook, Risks, and Contingencies
Conditional Resignation Clause: Both new directors, Ms. Field and Mr. Grasso, have agreed to promptly resign from the Board and any committees if an investment in the Company's equity securities of at least $5 million is not made within thirty (30) days of the filing of a Form S-1 Registration Statement (or within 30 days of clearing SEC comments, if applicable).
Committee Assignments: Ms. Field is expected to serve on the Audit and Compensation Committees. Mr. Grasso is expected to serve on the Audit and Nominating and Corporate Governance Committees.
Key Facts for Investor Verification
- Verify the status of the Form S-1 Registration Statement mentioned in the conditional resignation clause for the new directors.
- Confirm the timeline for the potential $5 million equity investment required to retain the new board members.
- Review the Company's upcoming capital raising activities given the board composition is contingent on a specific investment threshold.
- Check for any subsequent filings regarding the finalization of the Board's committee structures.